PTGS2 and cardiac hypertrophy: Ptgs2, malondialdehyde, and ROS levels substantially increase Ang II-induced cardiac hypertrophy; however, ferroptosis blocker xCT attenuates these changes, inhibiting cardiac hypertrophy (79).